Login
Navigate Fool.com

Biogen Idec

NASDAQ: BIIB

Community Rating: 4 Stars: Favorite

company name or ticker

3 Biotech Opportunities Following This Selloff

Here's a second chance to invest in companies with viable growth potential.

Health Care Stocks: Check Out This Low-Cost Market Beater

These health care stocks have been growing by double digits. Should you buy?

Biotech Bubble Bust: 2 Ways to Win

Why Gilead and Biogen are the best ways to play the biotech meltdown.

Are Biotechs Bad Medicine for the S&P 500?

Are biotechs to blame for the recent downturn in the S&P 500?

Why Biogen Idec Inc., Vertex Pharmaceuticals Incorporated, and Broadcom Corp. Are Today’s 3 Worst St

Health-care and high-growth names continue to stumble as a sell-off continues in the stock market today.

Tech stock rout continues in Asia

Asia tech stocks fall into the red

Stocks: Wall Street wears red

Why Gilead Sciences, AbbVie Inc., and Biogen Idec Are Today's 3 Worst Stocks

The 3 worst stocks in the stock market today all hail from the health care sector

Tweet of the Week: Big Biotech Dominates Industry Gains

Amgen, Biogen Idec, Celgene, Gilead Sciences, Regeneron Pharmaceuticals, and Alexion Pharmaceuticals make up 77% of the increase in the biotech sector over the past three years.

Does Biogen Idec Inc Have a New Blockbuster Hemophilia Therapy?

Biogen's Alprolix is now the most convenient hemophilia B treatment available, but competition is on the way.
See More Articles...
Featured Broker Partners